Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Actinium Pharmaceuticals (ATNM) Asset Utilization Ratio (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.0 as the latest value for Q2 2023.

  • On a quarterly basis, Asset Utilization Ratio fell 96.46% to 0.0 in Q2 2023 year-over-year; TTM through Jun 2023 was 0.0, a 96.46% decrease, with the full-year FY2023 number at 0.0, down 92.18% from a year prior.
  • Asset Utilization Ratio was 0.0 for Q2 2023 at Actinium Pharmaceuticals, down from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q1 2022 to a low of 0.0 in Q2 2023.
  • A 3-year average of 0.01 and a median of 0.01 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: soared 305.53% in 2022, then tumbled 96.46% in 2023.
  • Actinium Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2021, then plummeted by 35.74% to 0.01 in 2022, then crashed by 94.98% to 0.0 in 2023.
  • Per Business Quant, the three most recent readings for ATNM's Asset Utilization Ratio are 0.0 (Q2 2023), 0.0 (Q1 2023), and 0.01 (Q4 2022).